- List
- By Topic
- On Map
- Search Details

Recruiting, Not yet recruiting, Available Studies | "Neoplasms"
Need help? See RSS Feeds
Choose a feed type:

Recruiting, Not yet recruiting, Available Studies | "Neoplasms" (17175 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT03537378 | Not yet recruiting | Hybrid APC Therapy in Early Central Lung Neoplasms |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
30 | All | Child, Adult, Older Adult | NCT03537378 | SHCHE201801 | December 15, 2018 | May 30, 2019 | August 30, 2019 | May 25, 2018 | December 12, 2018 | ||||
2 | NCT02335112 | Recruiting | Irreversible Electroporation(IRE) For Unresectable Head and Neck Neoplasms |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
15 | All | Child, Adult, Older Adult | NCT02335112 | ZhangZhikai-IRE-02 | IRE | January 2015 | January 2017 | January 2020 | January 9, 2015 | March 29, 2016 |
|
||
3 | NCT02430649 | Recruiting | Irreversible Electroporation(IRE) For Unresectable Prostatic Neoplasms |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
30 | All | Child, Adult, Older Adult | NCT02430649 | Prostatic Neoplasms-IRE-01 | IRE | January 2015 | January 2017 | January 2020 | April 30, 2015 | March 29, 2016 |
|
||
4 | NCT02430636 | Recruiting | Irreversible Electroporation(IRE) For Unresectable Stomach Neoplasms |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
30 | All | Child, Adult, Older Adult | NCT02430636 | Stomach Neoplasms -IRE-01 | IRE | January 2015 | January 2017 | January 2020 | April 30, 2015 | March 29, 2016 |
|
||
5 | NCT02425059 | Recruiting | Irreversible Electroporation(IRE) For Unresectable Rectal Neoplasms |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
30 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT02425059 | Rectal cancer-IRE-01 | January 2015 | January 2017 | January 2020 | April 23, 2015 | March 29, 2016 |
|
|||
6 | NCT02430597 | Recruiting | Irreversible Electroporation(IRE) For Unresectable Hilus Pulmonis Neoplasms |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
30 | All | Child, Adult, Older Adult | NCT02430597 | hilus pulmonis -IRE-01 | IRE | January 2015 | January 2017 | January 2020 | April 30, 2015 | March 29, 2016 |
|
||
7 | NCT02430662 | Recruiting | Irreversible Electroporation(IRE) For Unresectable Gallbladder Neoplasms |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
30 | All | Child, Adult, Older Adult | NCT02430662 | Gallbladder Neoplasms-IRE-01 | IRE | January 2015 | January 2017 | January 2020 | April 30, 2015 | March 29, 2016 |
|
||
8 | NCT02430623 | Recruiting | Irreversible Electroporation(IRE) For Unresectable Urinary Bladder Neoplasms |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
30 | All | Child, Adult, Older Adult | NCT02430623 | Urinary Bladd Neoplasms-IRE-01 | IRE | January 2015 | January 2017 | January 2020 | April 30, 2015 | March 29, 2016 |
|
||
9 | NCT02430675 | Recruiting | Irreversible Electroporation(IRE) For Unresectable Laryngeal Neoplasms |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
30 | All | Child, Adult, Older Adult | NCT02430675 | Laryngeal Neoplasms-IRE-01 | IRE | January 2015 | January 2017 | January 2020 | April 30, 2015 | March 29, 2016 |
|
||
10 | NCT02430701 | Recruiting | Irreversible Electroporation(IRE) For Unresectable Esophageal Neoplasms |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
30 | All | Child, Adult, Older Adult | NCT02430701 | Esophageal Neoplasms -IRE-01 | IRE | January 2015 | January 2017 | January 2020 | April 30, 2015 | March 29, 2016 |
|
||
11 | NCT03838913 | Not yet recruiting New |
Whole-Exome Sequencing (WES) of Intraductal Neoplasms of the Bile Duct (IPNB) |
|
Observational |
|
Other |
|
|
60 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT03838913 | Fujian Provincial Hospital | WESIPNB | February 15, 2019 | June 30, 2019 | December 31, 2019 | February 12, 2019 | February 12, 2019 |
|
||||
12 | NCT02430610 | Recruiting | Irreversible Electroporation(IRE) For Uterine Cervical Neoplasms |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
30 | All | Child, Adult, Older Adult | NCT02430610 | Uterine Cerv cancer-IRE-01 | IRE | January 2015 | January 2017 | January 2020 | April 30, 2015 | March 29, 2016 |
|
||
13 | NCT02430779 | Recruiting | Irreversible Electroporation(IRE) For Unresectable Renal Pelvic and Ureteral Neoplasms |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
30 | All | Child, Adult, Older Adult | NCT02430779 | pelvis ureter Neoplasms-IRE-01 | IRE | January 2015 | January 2017 | January 2020 | April 30, 2015 | March 29, 2016 |
|
||
14 | NCT02557230 | Recruiting | Malignant Genito-urinary Tumors in Children: South Egypt Cancer Institute Experience |
|
Observational |
|
Other |
|
|
250 | All | up to 18 Years (Child, Adult) | NCT02557230 | Ped GU Tumors | January 2016 | March 2019 | April 2019 | September 23, 2015 | June 29, 2018 |
|
|||||
15 | NCT03719183 | Not yet recruiting | Comparison Between Fluorescent in Situ Hybridization Panels and Karyotyping in Hematological Neoplasms |
|
|
Observational |
|
Other |
|
|
100 | All | Child, Adult, Older Adult | NCT03719183 | AssiutU-SECI-Cytogenetic 100 | February 1, 2019 | January 31, 2020 | June 30, 2020 | October 25, 2018 | October 25, 2018 | |||||
16 | NCT03564821 | Recruiting | IDH1 Inhibition Using Ivosidenib as Maintenance Therapy for IDH1-mutant Myeloid Neoplasms Following Allogeneic Stem Cell Transplantation |
|
|
Interventional |
Phase 1 |
|
Other / Industry |
|
|
22 | All | 18 Years and older (Adult, Older Adult) | NCT03564821 | 18-123 | January 16, 2019 | July 31, 2021 | July 31, 2024 | June 21, 2018 | January 18, 2019 |
|
|||
17 | NCT02665676 | Not yet recruiting | Embryonal Tumors of Infancy & Childhood: South Egypt Cancer Institute Experience |
|
Observational |
|
Other |
|
|
420 | All | up to 18 Years (Child, Adult) | NCT02665676 | Ped Embryonal Tumors SECI | January 2019 | March 2019 | April 2019 | January 28, 2016 | June 29, 2018 |
|
|||||
18 | NCT02430753 | Recruiting | Irreversible Electroporation(IRE) For Lung Neoplasms Accompanied by Respiratory Function Insufficiency |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
30 | All | Child, Adult, Older Adult | NCT02430753 | lung fuction insuf-IRE-01 | IRE | January 2015 | January 2017 | January 2020 | April 30, 2015 | March 29, 2016 |
|
||
19 | NCT03333655 | Recruiting | Study to Explore the Mechanism of Acquired Immune Escape In Participants With Metastatic Cancer Progressing on CPI Therapy |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
100 | All | 18 Years and older (Adult, Older Adult) | NCT03333655 | ML40108 | February 16, 2018 | April 20, 2020 | April 20, 2020 | November 7, 2017 | January 9, 2019 |
|
|||
20 | NCT03024463 | Recruiting | The Multi-center Validation Study of Internal Mammary Lymph Biopsy With Modified Injection Technique in Breast Cancer Patients |
|
|
Observational |
|
Other |
|
|
200 | Female | 18 Years to 70 Years (Adult, Older Adult) | NCT03024463 | IMLN-VS | August 1, 2017 | March 1, 2019 | August 1, 2019 | January 18, 2017 | May 21, 2018 |
|
||||
21 | NCT03264664 | Recruiting | Study of E7386 in Subjects With Selected Advanced Neoplasms |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
140 | All | 18 Years and older (Adult, Older Adult) | NCT03264664 | E7386-G000-101 2016-004881-25 |
July 27, 2017 | November 29, 2019 | November 29, 2019 | August 29, 2017 | January 30, 2019 |
|
|||
22 | NCT03743480 | Recruiting | Early Palliative Care and Hematological Cancer Patients |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
60 | All | 18 Years and older (Adult, Older Adult) | NCT03743480 | 2018/0056350 | EPC-EMA1 | November 21, 2018 | November 2019 | July 2020 | November 16, 2018 | January 10, 2019 |
|
||
23 | NCT01104077 | Recruiting | Family and Personal History of Malignancy in Intraductal Papillary Mucinous Neoplasm (IPMN) |
|
Observational |
|
Other |
|
|
400 | All | 18 Years to 85 Years (Adult, Older Adult) | NCT01104077 | AAAD6106 | November 17, 2008 | July 2019 | July 2020 | April 15, 2010 | February 8, 2018 |
|
|||||
24 | NCT03511768 | Recruiting | A Study of 18F-AlF-NOTA-octreotide PET/CT for Imaging Neuroendocrine Neoplasms |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
65 | All | 18 Years and older (Adult, Older Adult) | NCT03511768 | 201801001 | January 2, 2018 | December 30, 2019 | December 30, 2020 | April 30, 2018 | April 30, 2018 |
|
|||
25 | NCT02557256 | Recruiting | Malignant Pediatric Pelvic Tumors: A Retrospective Study |
|
Observational |
|
Other |
|
|
90 | All | up to 18 Years (Child, Adult) | NCT02557256 | Ped Pelvi-abd Malig | January 2016 | November 2020 | December 2020 | September 23, 2015 | January 11, 2019 |
|
|||||
26 | NCT02679495 | Recruiting | Lifestyle Intervention for Prevention of Gastric Neoplasm |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
200 | All | Child, Adult, Older Adult | NCT02679495 | 2015WS0366 | March 2015 | December 2018 | December 2020 | February 10, 2016 | October 13, 2016 |
|
|||
27 | NCT03624712 | Recruiting | Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms |
|
|
Observational |
|
Other |
|
|
580 | Female | 18 Years and older (Adult, Older Adult) | NCT03624712 | ZGynO_DENOVA | January 2012 | January 2022 | December 2022 | August 10, 2018 | August 10, 2018 |
|
||||
28 | NCT03379428 | Recruiting | Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancer |
|
|
Interventional |
Phase 1 Phase 2 |
|
Industry |
|
|
51 | Female | 18 Years and older (Adult, Older Adult) | NCT03379428 | 14059 14-05914-059 |
November 29, 2017 | December 2019 | December 2021 | December 20, 2017 | December 21, 2017 |
|
|||
29 | NCT02869581 | Recruiting | Institut Paoli-Calmettes Pancreatic Neoplasms Database |
|
|
Observational |
|
Other |
|
|
8500 | All | 18 Years and older (Adult, Older Adult) | NCT02869581 | BDD-PANCREAS-IPC | January 2000 | January 2030 | December 2030 | August 17, 2016 | August 17, 2016 |
|
||||
30 | NCT03218345 | Recruiting | EUS-guided RFA for Pancreatic Neoplasms |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
30 | All | 18 Years and older (Adult, Older Adult) | NCT03218345 | CRE-2015.531T | August 2016 | May 2019 | May 2019 | July 14, 2017 | November 15, 2018 |
|
|||
31 | NCT03232164 | Recruiting | PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancer |
|
|
Interventional |
Early Phase 1 |
|
Other / NIH |
|
|
36 | Male | 18 Years and older (Adult, Older Adult) | NCT03232164 | UW16062 P30CA014520 2016-0883 |
February 2, 2017 | July 31, 2019 | July 31, 2020 | July 27, 2017 | January 11, 2019 |
|
|||
32 | NCT03368820 | Recruiting | Cardiovascular Morbidities and Lung Cancer Treatment: a Prospective Registry |
|
|
Observational |
|
Other |
|
|
200 | All | 18 Years and older (Adult, Older Adult) | NCT03368820 | 01151 | December 4, 2017 | December 31, 2019 | December 31, 2020 | December 11, 2017 | February 12, 2019 |
|
||||
33 | NCT03188991 | Recruiting | Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
30 | All | 18 Years and older (Adult, Older Adult) | NCT03188991 | NANOPAC-2017-01 | September 29, 2017 | December 2019 | December 2019 | June 16, 2017 | January 24, 2019 |
|
|||
34 | NCT03485547 | Recruiting | Study of Venetoclax, a BCL2 Antagonist, for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) |
|
|
Interventional |
Phase 1 |
|
Other / Industry |
|
|
26 | All | 18 Years and older (Adult, Older Adult) | NCT03485547 | 18-045 | August 23, 2018 | April 30, 2021 | April 30, 2025 | April 2, 2018 | October 15, 2018 |
|
|||
35 | NCT02117440 | Recruiting | Functional Image and Molecular Markers to Predict Treatment Outcomes in Lung Cancer |
|
Observational |
|
Other |
|
|
140 | All | 18 Years and older (Adult, Older Adult) | NCT02117440 | IUSCC-0596 GRU CC-13-24C |
April 2014 | January 1, 2022 | January 1, 2023 | April 21, 2014 | September 15, 2017 |
|
|||||
36 | NCT03094897 | Not yet recruiting | Clinic Study of 18F-Al-NOTA-MATBBN in Cancer Diagnostics |
|
|
Interventional |
Early Phase 1 |
|
Other |
|
|
30 | All | 18 Years and older (Adult, Older Adult) | NCT03094897 | Wuxi4PH | April 20, 2017 | December 31, 2020 | December 31, 2020 | March 29, 2017 | April 13, 2017 | ||||
37 | NCT03833700 | Not yet recruiting New |
A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC) |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
22 | All | 20 Years and older (Adult, Older Adult) | NCT03833700 | E7386-J081-103 | March 2019 | May 2021 | May 2021 | February 7, 2019 | February 7, 2019 | ||||
38 | NCT03217773 | Recruiting | ESD Versus TAMIS for Early Rectal Neoplasms |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
114 | All | 18 Years and older (Adult, Older Adult) | NCT03217773 | CREC Ref. No.: 2016.680-T | July 2017 | June 2019 | June 2019 | July 14, 2017 | July 17, 2017 |
|
|||
39 | NCT02085941 | Recruiting | Image-guided Cryoablation of Head, Neck and Spine Tumors |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
30 | All | 18 Years and older (Adult, Older Adult) | NCT02085941 | 13-458 | February 2015 | June 2019 | February 2021 | March 13, 2014 | March 6, 2018 |
|
|||
40 | NCT03524430 | Recruiting | RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy BREVITY |
|
|
Interventional |
Not Applicable |
|
Industry |
|
|
722 | Female | 18 Years and older (Adult, Older Adult) | NCT03524430 | RnaDx-BRV-BC- 01 | BREVITY | April 26, 2018 | April 26, 2025 | October 26, 2025 | May 14, 2018 | May 14, 2018 |
|
||
41 | NCT02809898 | Recruiting | The Role of ctDNA and PBMC in Treatment of Biliary Tract Cancer |
|
|
Observational |
|
Other |
|
|
30 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT02809898 | cfDNA-GCCC | July 2016 | July 2019 | July 2019 | June 22, 2016 | August 26, 2016 |
|
||||
42 | NCT02729493 | Recruiting | Study Evaluating the Efficacy and Safety With CAR-T for Liver Cancer |
|
|
Interventional |
Not Applicable |
|
Industry |
|
|
25 | All | up to 75 Years (Child, Adult, Older Adult) | NCT02729493 | ACCO-2015-06-03 | EECLC | November 14, 2015 | November 2019 | November 2019 | April 6, 2016 | March 15, 2017 |
|
||
43 | NCT02514512 | Recruiting | Lung Cancer Radiotherapy Using Realtime Dynamic Multileaf Collimator (MLC) Adaptation And Radiofrequency Tracking |
|
|
Interventional |
Phase 1 |
|
Other / Industry |
|
|
20 | All | 18 Years and older (Adult, Older Adult) | NCT02514512 | HREC/15/HAWKE/55 | LIGHTSABR | September 2015 | December 2019 | September 2022 | August 3, 2015 | January 24, 2019 |
|
||
44 | NCT03477162 | Recruiting | Metformin Pharmacology in Human Cancers: A Proof of Principle Study |
|
|
Interventional |
Early Phase 1 |
|
Other |
|
|
20 | All | 18 Years and older (Adult, Older Adult) | NCT03477162 | D17188 | May 15, 2018 | December 31, 2019 | December 31, 2019 | March 26, 2018 | January 25, 2019 |
|
|||
45 | NCT03023202 | Recruiting | UWCCC Molecular Tumor Board Registry |
|
|
Observational |
|
Other / NIH |
|
|
500 | All | 18 Years and older (Adult, Older Adult) | NCT03023202 | UW15068 2015-1370 P30CA014520 |
March 2016 | March 2021 | March 2021 | January 18, 2017 | February 16, 2018 |
|
||||
46 | NCT01862718 | Recruiting | Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms |
|
|
Interventional |
Phase 1 |
|
NIH |
|
|
10 | All | 18 Years to 84 Years (Adult, Older Adult) | NCT01862718 | 130079 13-CC-0079 |
November 19, 2013 | January 31, 2020 | January 31, 2021 | May 24, 2013 | November 12, 2018 |
|
|||
47 | NCT02953782 | Recruiting | Trial of Hu5F9-G4 in Combination With Cetuximab in Patients With Solid Tumors and Advanced Colorectal Cancer |
|
|
Interventional |
Phase 1 Phase 2 |
|
Industry |
|
|
112 | All | 18 Years and older (Adult, Older Adult) | NCT02953782 | 5F9004 | November 2016 | May 2020 | March 2023 | November 3, 2016 | August 1, 2018 |
|
|||
48 | NCT02989259 | Recruiting | Apatinib for Advanced Non-squamous Head and Neck Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
30 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT02989259 | CH-H&N-008-1 | December 2016 | December 2018 | December 2021 | December 12, 2016 | December 13, 2016 |
|
|||
49 | NCT03018418 | Recruiting | Proton Therapy in Reducing Toxicity in Anal Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
20 | All | 18 Years and older (Adult, Older Adult) | NCT03018418 | UCCI-GI-16-01 | January 2017 | June 2022 | January 2023 | January 12, 2017 | July 28, 2017 |
|
|||
50 | NCT03459846 | Recruiting | A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU) |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
150 | All | 18 Years to 130 Years (Adult, Older Adult) | NCT03459846 | D933IC00003 | BAYOU | March 16, 2018 | October 29, 2019 | June 28, 2021 | March 9, 2018 | January 25, 2019 |
|
||
51 | NCT02151123 | Not yet recruiting | Metabiomics Colon Cancer Clinical Research Study |
|
Observational |
|
Industry |
|
|
100 | All | 18 Years to 95 Years (Adult, Older Adult) | NCT02151123 | MB-02_CU | March 2019 | March 2020 | September 2020 | May 30, 2014 | August 15, 2018 |
|
|||||
52 | NCT02747342 | Recruiting | A Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate Cancer |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
51 | Male | 18 Years and older (Adult, Older Adult) | NCT02747342 | SHR3680-002 | September 2016 | June 2020 | September 2020 | April 21, 2016 | December 3, 2018 |
|
|||
53 | NCT02776917 | Recruiting | Study of Cirmtuzumab and Paclitaxel for Metastatic or Locally Advanced, Unresectable Breast Cancer |
|
|
Interventional |
Phase 1 |
|
Other / Industry |
|
|
20 | All | 18 Years and older (Adult, Older Adult) | NCT02776917 | 160178 | August 15, 2018 | June 2020 | June 2021 | May 18, 2016 | August 17, 2018 |
|
|||
54 | NCT03791853 | Recruiting | Light-CT in the Diagnosis of Breast Tumor and Lymph Node |
|
|
Observational |
|
Other |
|
|
150 | Female | 18 Years to 90 Years (Adult, Older Adult) | NCT03791853 | LightCT-PKUPH | April 1, 2018 | May 1, 2019 | December 31, 2019 | January 3, 2019 | January 3, 2019 |
|
||||
55 | NCT03023436 | Recruiting | Cytoreductive Surgery Combined With HIPEC and Chemotherapy for Gastric Cancer With Peritoneal Metastasis |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
220 | All | 19 Years to 74 Years (Adult, Older Adult) | NCT03023436 | CLASS - 05 | January 2016 | June 2022 | June 2022 | January 18, 2017 | February 7, 2017 |
|
|||
56 | NCT03787966 | Not yet recruiting | Attenuating Cancer Treatment-related Toxicity in Oncology Patients With a Tailored Physical Exercise Program |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
110 | Female | 18 Years to 70 Years (Adult, Older Adult) | NCT03787966 | ATOPE18 | ATOPE | January 31, 2019 | March 31, 2020 | December 31, 2021 | December 27, 2018 | December 27, 2018 |
|
||
57 | NCT02834494 | Recruiting | Assessment of Response to Neo-adjuvant Chemotherapy for Patients With a Locally Advanced Breast Cancer With 3D Elastography (Shear Wave), |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
140 | All | 18 Years and older (Adult, Older Adult) | NCT02834494 | IC 2015-07 | NEO-ELASTO | February 2016 | February 2020 | October 2020 | July 15, 2016 | December 12, 2018 |
|
||
58 | NCT03099174 | Recruiting | This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer. |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
148 | All | 18 Years and older (Adult, Older Adult) | NCT03099174 | 1280.18 2016-003142-85 |
May 4, 2017 | April 10, 2020 | November 8, 2021 | April 4, 2017 | February 5, 2019 |
|
|||
59 | NCT03252509 | Recruiting | Outpatient Percutaneous Radiologic Gastrostomy in Patients With Head and Neck Tumors |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
35 | All | 18 Years and older (Adult, Older Adult) | NCT03252509 | INCA RI | March 20, 2017 | October 30, 2018 | December 31, 2018 | August 17, 2017 | March 19, 2018 |
|
|||
60 | NCT01585675 | Recruiting | Specimen Banking From Patients With Lung Cancer |
|
Observational |
|
Other / NIH |
|
|
1000 | All | 18 Years to 85 Years (Adult, Older Adult) | NCT01585675 | 04-0688 P50CA058187 |
November 2005 | May 2019 | May 2020 | April 26, 2012 | June 15, 2018 |
|
|||||
61 | NCT03622983 | Recruiting | Cohort of Patients With Pelvic Gynecological Cancer: Constitution of a Collection of Biological Samples With Radioclinic Characterization |
|
|
Observational |
|
Other |
|
|
500 | Female | 18 Years and older (Adult, Older Adult) | NCT03622983 | PELVIMASS2 2016-A00613-48 |
PELVIMASS2 | May 1, 2017 | April 2022 | May 2032 | August 9, 2018 | August 9, 2018 |
|
|||
62 | NCT02494258 | Recruiting | A Study to Evaluate Long-term Safety in Subjects With Solid Tumors and Hematological Disorders. |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
125 | All | 18 Years and older (Adult, Older Adult) | NCT02494258 | CC-486-GEN-001 | October 22, 2015 | November 30, 2020 | December 31, 2020 | July 10, 2015 | November 22, 2018 |
|
|||
63 | NCT02964507 | Recruiting | Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancer |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
294 | Female | 18 Years and older (Adult, Older Adult) | NCT02964507 | 201973 | February 2, 2017 | April 23, 2020 | June 1, 2020 | November 16, 2016 | October 17, 2018 |
|
|||
64 | NCT02725125 | Recruiting | Study Evaluating the Efficacy and Safety With CAR-T for Stomach Cancer |
|
|
Interventional |
Not Applicable |
|
Industry |
|
|
19 | All | up to 75 Years (Child, Adult, Older Adult) | NCT02725125 | ACCO-2015-06-04 | EECSC | November 2015 | November 2019 | November 2019 | March 31, 2016 | March 23, 2017 |
|
||
65 | NCT02229916 | Recruiting | Swiss Austrian German Testicular Cancer Cohort Study - SAG TCCS |
|
Observational |
|
Other |
|
|
6900 | Male | 18 Years and older (Adult, Older Adult) | NCT02229916 | SG359/13 | SAG TCCS | December 2013 | September 2019 | September 2029 | September 3, 2014 | January 30, 2019 |
|
||||
66 | NCT03111615 | Not yet recruiting | HOrmone Therapy Immediately After Histological Diagnosis of Breast Cancer |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
90 | Female | 50 Years and older (Adult, Older Adult) | NCT03111615 | CentroHLOBreastUnit | HOTBreast | May 1, 2018 | May 1, 2019 | May 1, 2020 | April 13, 2017 | December 5, 2017 |
|
||
67 | NCT02836769 | Recruiting | Development and Evaluation of Rehabilitation Consult for Survivors of Head and Neck Cancer |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
35 | All | 18 Years and older (Adult, Older Adult) | NCT02836769 | 246-2013 | HNC-RC | January 2016 | December 2017 | May 2018 | July 19, 2016 | April 27, 2017 |
|
||
68 | NCT02948764 | Recruiting | Diagnosis of Pathological Complete Response by Vacuum-assisted Biopsy After Neoadjuvant Chemotherapy in Breast Cancer |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
600 | Female | 18 Years and older (Adult, Older Adult) | NCT02948764 | 2 | RESPONDER | March 8, 2017 | March 2020 | September 2020 | October 28, 2016 | November 27, 2018 |
|
||
69 | NCT03838042 | Not yet recruiting New |
INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
128 | All | 6 Years to 21 Years (Child, Adult) | NCT03838042 | Final2, 09-01-2019 2018-000127-14 NCT-2017-0516 |
INFORM2 NivEnt | March 2019 | September 2022 | March 2023 | February 12, 2019 | February 12, 2019 | |||
70 | NCT03583944 | Recruiting | A Study to Evaluate Safety, Tolerability and Efficacy of Eribulin Mesylate in Treating Adult Females With Locally Advanced or Metastatic Breast Cancer |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
83 | Female | 18 Years and older (Adult, Older Adult) | NCT03583944 | E7389-M065-401 | March 28, 2018 | February 2019 | June 2019 | July 12, 2018 | February 7, 2019 |
|
|||
71 | NCT03221335 | Recruiting | EUS-guided RFA for Solid Abdominal Neoplasms |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
30 | All | 18 Years and older (Adult, Older Adult) | NCT03221335 | CRE-2015.707 | May 2016 | April 2021 | April 2021 | July 18, 2017 | November 15, 2018 |
|
|||
72 | NCT03743428 | Recruiting | Biomarkers for Apatinib and Bevacizumab in Second-line Therapy for Colorectal Cancer(BABST-C) |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
40 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT03743428 | Shenzhen CRC-003 | BABST-C | December 1, 2018 | November 1, 2022 | December 31, 2022 | November 16, 2018 | November 16, 2018 |
|
||
73 | NCT03587285 | Not yet recruiting | A Pilot Study of Hormonal Therapy Combined With Central Memory T Cells (Tcm) for Patients With Advanced Prostate Cancer |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
60 | Male | 18 Years to 90 Years (Adult, Older Adult) | NCT03587285 | S2017-05-01 | July 10, 2018 | June 30, 2021 | July 31, 2021 | July 16, 2018 | July 16, 2018 | ||||
74 | NCT02943252 | Recruiting | The Clinical Study of Apatinib Plus S1 for Patients With Advanced Non-squamous Head and Neck Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
30 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT02943252 | CH-H&N-008 | October 2016 | October 2019 | October 2021 | October 24, 2016 | October 24, 2016 |
|
|||
75 | NCT03739775 | Not yet recruiting | Circulating Tumor DNA for the Early Detection of HPV-positive Pelvic Cancer Relapses |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
172 | All | 18 Years to 79 Years (Adult, Older Adult) | NCT03739775 | IC 2017-01 CIRCA-HPV | CIRCA-HPV | December 1, 2018 | December 1, 2023 | December 1, 2023 | November 14, 2018 | November 14, 2018 |
|
||
76 | NCT03604237 | Recruiting | Targeted Forceps Biopsy for Colorectal Tumors |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
64 | All | 19 Years to 85 Years (Adult, Older Adult) | NCT03604237 | KNUH201804 | September 1, 2017 | August 1, 2018 | October 1, 2018 | July 27, 2018 | July 27, 2018 |
|
|||
77 | NCT03435380 | Not yet recruiting | Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer |
|
|
Interventional |
Not Applicable |
|
Other / NIH |
|
|
291 | Female | 25 Years and older (Adult, Older Adult) | NCT03435380 | Pro00088926 R01CA134722 |
March 29, 2019 | October 31, 2020 | April 30, 2021 | February 16, 2018 | February 7, 2019 |
|
|||
78 | NCT03429907 | Recruiting | An Early Stress-Reduction Intervention in Patients With Newly Diagnosed Breast Cancer |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
140 | Female | 18 Years and older (Adult, Older Adult) | NCT03429907 | 2016-0600 | December 5, 2017 | December 2019 | December 2020 | February 12, 2018 | May 11, 2018 |
|
|||
79 | NCT02984761 | Recruiting | Veterans Affairs Lung Cancer Or Stereotactic Radiotherapy |
|
|
Interventional |
Not Applicable |
|
U.S. Fed |
|
|
670 | All | 18 Years and older (Adult, Older Adult) | NCT02984761 | 2005 | VALOR | April 13, 2017 | September 30, 2026 | September 30, 2027 | December 7, 2016 | December 13, 2018 |
|
||
80 | NCT03648359 | Not yet recruiting | Multiparametric MRI in Men With Prostate Cancer Enrolled in Active Surveillance |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
200 | Male | 18 Years to 75 Years (Adult, Older Adult) | NCT03648359 | AS | September 2018 | January 2020 | January 2020 | August 27, 2018 | August 27, 2018 | ||||
81 | NCT02960308 | Recruiting | Whole-Neck Computed Tomography Perfusion Scan in Imaging Patients With Head and Neck Tumors |
|
|
Interventional |
Not Applicable |
|
Other / NIH |
|
|
50 | All | 18 Years and older (Adult, Older Adult) | NCT02960308 | 7H-16-2 NCI-2016-01583 P30CA014089 |
October 20, 2016 | October 20, 2018 | April 20, 2019 | November 9, 2016 | November 17, 2017 |
|
|||
82 | NCT02701231 | Recruiting | Low-frequency Rotating Magnetic System Combined With Systemic Anti-tumor Therapy for Advanced Lung Cancer |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
200 | All | 18 Years and older (Adult, Older Adult) | NCT02701231 | S2015-093-01 | November 2015 | December 2020 | December 2020 | March 8, 2016 | March 9, 2016 |
|
|||
83 | NCT02017288 | Recruiting | Study to Evaluate the Natural History of Head and Neck Cancer Precursors in Taiwan |
|
Observational |
|
NIH / Other |
|
|
5000 | All | 21 Years to 100 Years (Adult, Older Adult) | NCT02017288 | 999914018 14-C-N018 |
December 19, 2013 | November 30, 2025 | November 30, 2025 | December 20, 2013 | February 8, 2019 |
|
|||||
84 | NCT02226224 | Recruiting | Endoscopic Ultrasound in Detailed T-staging of Upper GI Malignancies in Vitro |
|
Observational |
|
Other |
|
|
120 | All | 18 Years and older (Adult, Older Adult) | NCT02226224 | EC1001 | June 2014 | October 2020 | October 2020 | August 27, 2014 | July 18, 2017 |
|
|||||
85 | NCT02637687 | Recruiting | Oral TRK Inhibitor LOXO-101 (Larotrectinib) for Treatment of Advanced Pediatric Solid or Primary Central Nervous System Tumors |
|
|
Interventional |
Phase 1 Phase 2 |
|
Industry |
|
|
112 | All | up to 21 Years (Child, Adult) | NCT02637687 | 20290 LOXO-TRK-15003 |
SCOUT | December 2015 | June 2019 | December 2019 | December 22, 2015 | February 15, 2019 |
|
||
86 | NCT03277898 | Not yet recruiting | Aerobic Exercise and Cognitive Functioning in Women With Breast Cancer |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
84 | Female | 19 Years to 65 Years (Adult, Older Adult) | NCT03277898 | H17-00563 | ACTIVATE | November 1, 2017 | November 1, 2019 | November 1, 2020 | September 11, 2017 | September 11, 2017 |
|
||
87 | NCT02041312 | Recruiting | Serum Cholesterol and Gastric Neoplasm |
|
|
Observational |
|
Other |
|
|
1178 | All | Child, Adult, Older Adult | NCT02041312 | AMC-1312 KCHUGRFG1312 |
SCGN | February 2014 | December 2018 | June 2019 | January 22, 2014 | December 6, 2016 |
|
|||
88 | NCT03314896 | Recruiting | Laparoscopic Surgery for T4 Tumor of the Colon Cancer (LST4C Trial) |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
957 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT03314896 | LST4C trial | October 2016 | October 2019 | October 2024 | October 19, 2017 | November 6, 2018 |
|
|||
89 | NCT02668276 | Recruiting | Engaging Newly Diagnosed Men About Cancer Treatment Options |
|
|
Interventional |
Not Applicable |
|
Other / U.S. Fed / Industry |
|
|
300 | Male | up to 76 Years (Child, Adult, Older Adult) | NCT02668276 | 2015-1294 W81XWH-14-PCRP-BDA |
ENACT | April 2016 | August 2022 | August 2022 | January 29, 2016 | May 16, 2018 |
|
||
90 | NCT03219268 | Recruiting | A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
243 | All | 18 Years and older (Adult, Older Adult) | NCT03219268 | CP-MGD013-01 | August 18, 2017 | June 2020 | August 2022 | July 17, 2017 | November 20, 2018 |
|
|||
91 | NCT02852915 | Not yet recruiting | Laparoscopic Surgery for T4 Tumor of the Colon Cancer |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
1960 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT02852915 | LapT4 | October 2016 | October 2019 | October 2024 | August 2, 2016 | August 4, 2016 | ||||
92 | NCT01374841 | Recruiting | Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
20 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT01374841 | IEO S513/110 2009-018083-94 |
August 2010 | August 2019 | December 2019 | June 16, 2011 | September 20, 2018 |
|
|||
93 | NCT03323346 | Recruiting | Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
150 | Female | 18 Years and older (Adult, Older Adult) | NCT03323346 | 2016-1-DSF-MBC | DISC | September 29, 2017 | December 31, 2019 | September 30, 2020 | October 27, 2017 | November 27, 2018 |
|
||
94 | NCT00200486 | Recruiting | Molecular and Genomic Profiling of Head and Neck Tumors |
|
Observational |
|
Other / NIH |
|
|
400 | All | Child, Adult, Older Adult | NCT00200486 | 02-05-127E NIH-R21-CA104402 6R21DE023941-03 |
May 2002 | May 2020 | May 1, 2020 | September 20, 2005 | August 1, 2018 |
|
|||||
95 | NCT03415763 | Recruiting | Adjuvant Chemotherapy in Patients With Clinical Stage III Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
764 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT03415763 | Fudan AC | November 5, 2018 | December 2020 | December 2025 | January 30, 2018 | November 6, 2018 |
|
|||
96 | NCT03564938 | Recruiting | Regorafenib in Indian Patients With Metastatic Colorectal Cancer (mCRC). |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
100 | All | 18 Years and older (Adult, Older Adult) | NCT03564938 | 19214 | July 30, 2018 | October 19, 2020 | October 19, 2020 | June 21, 2018 | February 5, 2019 |
|
|||
97 | NCT02997241 | Not yet recruiting | Colon Cancer Treatment Decisions and Recurrence Predicting |
|
|
Interventional |
Not Applicable |
|
Industry / Other |
|
|
500 | All | 18 Years and older (Adult, Older Adult) | NCT02997241 | MG-WXu | CCTDRP | January 2017 | December 2017 | September 2022 | December 20, 2016 | December 20, 2016 |
|
||
98 | NCT03546322 | Recruiting | Customized Registry Tool for Tracking Adherence to Clinical Guidelines for Head and Neck Cancers |
|
|
Observational |
|
Other / U.S. Fed |
|
|
400 | All | 18 Years and older (Adult, Older Adult) | NCT03546322 | P30HS023558-1 P30HS023558 |
June 1, 2018 | May 2019 | May 2023 | June 5, 2018 | October 11, 2018 |
|
||||
99 | NCT03164993 | Recruiting | Atezolizumab Combined With Immunogenic Chemotherapy in Patients With Metastatic Triple-negative Breast Cancer |
|
|
Interventional |
Phase 2 |
|
Other / Industry |
|
|
75 | All | 18 Years and older (Adult, Older Adult) | NCT03164993 | ML39079_ALICE | ALICE | June 1, 2017 | November 1, 2020 | March 1, 2024 | May 24, 2017 | November 8, 2018 |
|
||
100 | NCT03069742 | Recruiting | Study of Web-based Decision Aids for Increasing Breast Cancer Chemoprevention in the Primary Care Setting |
|
|
Interventional |
Not Applicable |
|
Other / NIH |
|
|
350 | Female | 35 Years to 75 Years (Adult, Older Adult) | NCT03069742 | AAAP4151 II R01CA177995 |
November 2016 | April 2019 | April 2019 | March 3, 2017 | May 11, 2017 |
|
† Study has passed its completion date and status has not been verified in more than two years.